COMP <GO>
OPTH vs BFRI // EV/EBITDA & P/E VALUATION
Optimi Health Corp. (NASDAQ) VS. Biofrontera Inc. (NASDAQ) • 15-METRIC TALLY: OPTH 1
— BFRI 1
■ METRIC PARITY
LAST: $2.60 (-6.81%) • MKT CAP: $14.9M
valuation
—
LAST: $0.93 (+5.09%) • MKT CAP: $13.8M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OPTH VS. BFRI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OPTH | BFRI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -27.20% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -25.30% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 11.70% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 3/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 18.3 | 42.2 | -23.90 | BFRI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.9M | $13.8M | $1.1M | OPTH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OPTH REV | BFRI REV | OPTH GROSS % | BFRI GROSS % | OPTH FCF | BFRI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $41.7M | — | — | — | -$13.4M |
| FY 2024 | — | $37.3M | — | — | — | -$10.3M |
| FY 2023 | — | $34.1M | — | — | — | -$24.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OPTH // BETA —
BFRI // BETA —